Thus, sufficient evidence of particular PKC isozyme abnormalities, as provided by the results of the current study, may help in the development of neurotherapeutic drugs or other treatment approaches specifically targeting the PKC signaling system and could help to improve the effectiveness of treatments for depression treatment, thus reducing suicide attempts. The gene discussed is PRRT2; the disease is depressive symptom measurement.